Michael Rose

56 papers receiving 2.5k citations

Michael Rose's Hit Papers

SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice 2013 · 402 citations
4020+4+8Years since publication100200300400

Peers

Michael Rose
Comparison fields: 5 of 144
  • Endocrinology, Diabetes and Metabolism 846
  • Nephrology 341
  • Immunology and Allergy 290
  • Anesthesiology and Pain Medicine 185
  • Dermatology 236
Replace Marco Bertolotti with:
Marco Bertolotti Italy
Hong Lü United States
M. McLaren United Kingdom
Huang‐Ping Yu Taiwan
Olavi Ylikorkala Finland
Hui Peng China
Stylianos Kapiotis Austria
Kishio Nanjo Japan
Pius Hildebrand Switzerland
Gregorio Caimi Italy
Michael Rose relative to Marco Bertolotti Italy Marco Bertolotti's profile →
Citations per field
00.5×10×13.2×
Marco Bertolotti · 1×
Citations per year

Countries citing papers authored by Michael Rose

Since Specialization
Citations

This map shows the geographic impact of Michael Rose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Rose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Rose more than expected).

Fields of papers citing papers by Michael Rose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Rose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Rose. The network helps show where Michael Rose may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Rose, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Rose Line = papers co-authored together Michael Rose links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.

#Work
1
SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice
Hit paper breakdown →
2013402
2 2002396
3 2012330
4 2012156
5 2007151
6 2012132
7 201297
8 201985
9 200169
10 201769
11 200566
12 201959
13 200753
14 200646
15 200642
16 201239
17 201539
18 202236
19 200535
20 200529

About Michael Rose

Michael Rose is a scholar working on Immunology and Allergy, Pharmacology, Surgery, Endocrinology, Diabetes and Metabolism and Physiology, having authored 56 papers that have together received 2.6k indexed citations. Recurring topics across this work include Food Allergy and Anaphylaxis Research (14 papers), Drug-Induced Adverse Reactions (8 papers), Contact Dermatitis and Allergies (7 papers), Diabetes Treatment and Management (6 papers), Pancreatic function and diabetes (6 papers), Allergic Rhinitis and Sensitization (5 papers), Folate and B Vitamins Research (4 papers) and Diabetes Management and Research (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (846 citations), Nephrology (341 citations), Immunology and Allergy (290 citations), Anesthesiology and Pain Medicine (185 citations) and Dermatology (236 citations). Michael Rose has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Peter Kam, Volker Vallon, Maria Gerasimova, Timo Rieg, Hermann Koepsell, Scott C. Thomson, Joseph Satriano, Brian A. Baldo, Takahiro Masuda and M. McD. Fisher. Their work appears in journals such as British Journal of Anaesthesia, Transfusion, Acta Anaesthesiologica Scandinavica, American Journal of Physiology-Renal Physiology and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact